血管内取栓术前自动化脑萎缩测量与功能预后相关
自动化脑萎缩测量与取栓后功能预后相关。
要点
- 颅内脑脊液体积占比每增加5%,功能独立(mRS 0–2)的OR为0.65。
- 脑脊液体积占比与3个月mRS评分升高相关(common OR=1.59)。
- 该自动化影像标志物有望用于取栓决策支持,但需外部验证。
核心结论
- 基于CT自动化测量的颅内脑脊液体积所反映的脑萎缩,与血管内取栓患者3个月功能预后独立相关。
研究设计与样本
- 用经验证的U-Net结合Hounsfield单位阈值分割CT脑扫描。
- 以颅内脑脊液体积占总颅内体积的比例作为脑萎缩标志物。
主要发现
- 204例(56.7%)患者达到功能独立(3个月mRS 0–2)。
- 脑脊液体积平均±SD为总颅内体积的9.0±4.7%。
- 多变量回归显示脑脊液体积每增加5%,功能独立OR=0.65(95%CI 0.48–0.89;P=0.007)。
- 脑脊液体积每增加5%,3个月mRS评分升高的common OR=1.59(95%CI 1.05–2.41;P=0.03)。
临床怎么用
- 该自动化、客观的脑萎缩影像标志物若获未来研究验证,可考虑纳入决策支持工具以改善医患共同治疗决策。
局限性
- 单中心注册研究设计。
- 结论需在未來研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Methods of identifying ischemic stroke patients with a greater probability of poor outcome following endovascular thrombectomy (EVT) might improve shared treatment decision-making between patients, families, and physicians. We used an objective, automated method to measure cerebral atrophy and investigated whether this was associated with outcome in EVT patients. Methods- Consecutive EVT patients from a single-center registry were studied. CT brain scans were segmented with a combination of a validated U-Net and Hounsfield unit thresholding. Intracranial cerebrospinal fluid (CSF) volume was used as a marker of cerebral atrophy and calculated as a proportion of total intracranial volume. The primary outcome was functional independence, defined as a 3-month modified Rankin Scale score of 0 to 2. Results- Three-hundred sixty EVT patients were included. Functional independence was achieved in 204 (56.7%) patients. The mean±SD CSF volume was 9.0±4.7% of total intracranial volume. Multivariable regression demonstrated that increasing CSF volume was associated with reduced functional independence (OR=0.65 per 5% increase in CSF volume; 95% CI, 0.48-0.89; P=0.007) and higher 3-month modified Rankin Scale scores (common OR, 1.59 per 5% increase in CSF volume; 95% CI, 1.05-2.41; P=0.03). Conclusions- Cerebral atrophy determined by automated measurement of intracranial CSF volume is associated with functional outcome in patients undergoing EVT. If validated in future studies, this simple, objective, and automated imaging marker could potentially be incorporated into decision-support tools to improve shared treatment decision-making.
引用
- Diprose WK, Diprose JP, Wang MTM, et al. Automated Measurement of Cerebral Atrophy and Outcome in Endovascular Thrombectomy. Stroke. 2019. PMID: 31558139. doi:10.1161/STROKEAHA.119.027120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。